GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (OTCPK:MROPF) » Definitions » Additional Paid-In Capital

MROPF (MicroPort CardioFlow Medtech) Additional Paid-In Capital : $572.97 Mil(As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort CardioFlow Medtech Additional Paid-In Capital?


MicroPort CardioFlow Medtech's quarterly additional paid-in capital declined from Dec. 2023 ($584.20 Mil) to Jun. 2024 ($575.02 Mil) but then stayed the same from Jun. 2024 ($575.02 Mil) to Dec. 2024 ($572.97 Mil).

MicroPort CardioFlow Medtech's annual additional paid-in capital declined from Dec. 2022 ($597.29 Mil) to Dec. 2023 ($584.20 Mil) and declined from Dec. 2023 ($584.20 Mil) to Dec. 2024 ($572.97 Mil).


MicroPort CardioFlow Medtech Additional Paid-In Capital Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Additional Paid-In Capital Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial 73.68 651.71 597.29 584.20 572.97

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 597.29 582.03 584.20 575.02 572.97

MicroPort CardioFlow Medtech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

MicroPort CardioFlow Medtech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort CardioFlow Medtech Business Description

Traded in Other Exchanges
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.